Poland· PL-100450690

Naloxone Accord

A naloxone product containing naloxoni hydrochloridum, registered in Poland by Accord Healthcare Polska Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.

ATC V03AB15

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedNaloxone AccordATCV03AB15REGISTER NO.PL-100450690PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Naloxone is registered in 11 of 19 countries.

Countries holding a registration under ATC V03AB15 (naloxone), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Naloxone · ATC V03AB15

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Naloxoni hydrochloridum
Manufacturer
Accord Healthcare Polska Sp. z o.o.
Country
Poland (PL)
ATC code
V03AB15
ATC class
Naloxone
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991523138

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

104 interactions on record for naloxone.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Naloxone · interactions on record

104 records

  • 2 severe
  • 34 moderate
  • 4 minor
  • 64 info

Most severe, free to view

  • DroperidolN01AX01severe
  • DroperidolN05AD08severe
  • Methylnaltrexone bromideA06AH01moderate
  • NaloxegolA06AH03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Naloxone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All naloxone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Forvel, Naloxon Accord
  • Belgium · Naloxon B. Braun
  • Bulgaria · Форвел
  • Cyprus · Codaxol, Forvel
  • Czechia · Forvel, Naloxone Polpharma
  • Germany · Naloxon Accord, Naloxon B. Braun
  • Denmark · Forvel, Naloxon B. Braun
  • Estonia · Forvel, Ventizolve
  • Spain · Fomed, Naloxona B. Braun
  • Finland · Naloxone Accord, Nexodal
  • France · Naloxone Accord, Naloxone Adapt Pharma
  • United Kingdom (Northern Ireland) · Naloxone Accord-Uk, Naloxone B. Braun Melsungen
  • Greece · Forvel, Νaloxon B.Braun
  • Croatia · Forvel
  • Hungary · Nexodal
  • Ireland · Naloxone Hydrochloride Accord, Naloxone Hydrochloride Mercury Pharmaceuticals (Ireland)
  • Iceland · Naloxon B. Braun, Nyxoid
  • Italy · Naloxone Accord, Naloxone Adapt
  • Liechtenstein · Nyxoid
  • Lithuania · Forvel
  • Luxembourg · Naloxon B. Braun
  • Latvia · Forvel
  • Malta · Forvel
  • Netherlands · Naloxon Hci B. Braun, Naloxon Hcl Accord
  • Norway · Naloxon B. Braun, Naloxon Hameln
  • Portugal · Forvel, Naloxona Accord
  • Romania · Forvel
  • Sweden · Naloxon Actrevo, Naloxon Hameln
  • Slovenia · Nexodal
  • Slovakia · Naloxone Polpharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/777e4ba5-808a-4124-b583-d89e491ab519
GET /v1/drugs/777e4ba5-808a-4124-b583-d89e491ab519?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do wstrzykiwań lub infuzji w ampułko-strzykawce",
  "source": "urpl",
  "strength": "400 mcg/ml",
  "packaging": "05909991523138 ¦ Lz ¦ 151592\n1 amp.-strzyk. 1 ml",
  "substance": "Naloxoni hydrochloridum 400 mcg/ml",
  "common_name": "Naloxoni hydrochloridum",
  "pl_product_id": "100450690",
  "pozwolenie_nr": "28062",
  "auth_procedure": "DCP",
  "authorisation_validity": "2026-06-17"
}

See everything about naloxone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.